Drugs / Allogeneic Young Plasma
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04241159 | May → Aug 2020 | heart failure | Wake Forest University Health Sciences | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Young Plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04241159 ↗ |
| Route | Intravenous | “administering plasma (PF24) acquired from donors of a young chronological age intravenously” NCT04241159 ↗ |